How do agribusiness corporations impact decisions on our food system?
This week's European Commission decision to extend Glyphosate's market authorisation points to many broader problems - here is a CEO overview of the issues at large.
The official EU assessment of glyphosate was based on unpublished studies owned by industry. Seven months later, the pesticide industry still fights disclosure and, so far, successfully. We obtained a copy of their arguments.
The European Commission proposal on scientific criteria defining endocrine disruptors (EDCs) is the latest dangerous outgrowth of a highly toxic debate. The chemical lobby, supported by certain Commission factions (notably DG SANTE and the Secretary-General) and some member states (UK and Germany), has put significant obstacles in the way of effective public health and environment regulation.
There are many fundamental flaws in the argumentation they are putting forward. In a guest article, Claire Robinson of GMWatch rebutts many of the claims made by those green activists who have recently “come out” as GMO-proponents.
On 15 June 2016, the Commission will finally announce the long-awaited scientific criteria for EDCs. Time to do a recap of this last season’s main episodes.
This May is dense on the EU chemicals regulation front. Crunch time for two major files: the European Commission needs to publish the identification criteria for endocrine disrupting chemicals, and together with EU States must decide how, or not, renew the market approval of glyphosate, an herbicide produced and defended by Monsanto. Last week, the Professor Alan Boobis happened to be involved in both.
Demonstrating the problematic symbiosis between corporate interests and EU institutions, the same lobbying consultancies often get hired by both.
The biotech industry is staging an audacious bid to have a whole new generation of genetic engineering techniques excluded from European regulations. The pending decision of the European Commission on the regulation of these so-called 'new GMOs' represents a climax point in the ongoing below-the-radar attack by industry on GM laws.
An investigation led by research and campaign group Corporate Europe Observatory (CEO) and journalist Stéphane Horel exposes corporate lobby groups mobilising to stop the EU taking action on hormone (endocrine) disrupting chemicals (EDCs). The report sheds light on how corporations and their lobby groups have used numerous tactics from the corporate lobbying playbook: scaremongering, evidence-discrediting, and delaying tactics as well as the ongoing TTIP negotiations as a leverage.
The EU Food Safety Authority refuses to disclose new Director's Declaration of Interests and its own assessment of this person's interests.
An Open Letter to the European Parliament's Budget Control Committee
The relicensing procedure for one of the world's most widely used herbicides
We are a small team that works fully independently of funding from EU
institutions and corporations.
Every single donation helps us fight the hold of Big Business over the EU.